Kyverna Therapeutics Inc.
XNAS: KYTX
Kyverna Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart
about
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product, KYV-101, is an autologous CD19 CAR T-cell product candidate made...
Read More
4.10
0.20
(5.13%)
331.4K
XNAS Volume
XNAS 09 Sep, 2025 5:30 PM (EDT)
Board Meeting
The board meeting for Kyverna Therapeutics Inc. is scheduled for today, for the purpose of H.C. Wainwright 27th Annual Global Investment Conference
See details
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Kyverna Therapeutics Inc. Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..